|
⚲
|
| Keyboard |
| InvOpps GP IV LLC
✚
|
|
|---|---|
| CIK # | 0001792570 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001792570] | |
| 4 | [0001792570] | |
| SC 13D | [0001792570] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Invopps GP IV LLC | Oyster Point Pharma Inc | [2019-11-14] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| InvOpps GP IV LLC | |
| InvOpps IV LP | |
| Oyster Point Pharma Inc | |
| InvOpps IV US LP | |
| Lainovic Sacha |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2023-01-03 | Tender | 917,768 | ||
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2023-01-03 | Tender | 1,850,818 | ||
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2020-05-19 | Buy | 59,178 | $28.00 | 1,656,984 |
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2020-05-19 | Buy | 119,393 | $28.00 | 3,343,004 |
|
Oyster Point Pharma Inc OYST
Series B Convertible Preferred Stock · derivative
|
2019-11-04 | Conversion | 1,230,050 | ||
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2019-11-04 | Conversion | 1,230,050 | ||
|
Oyster Point Pharma Inc OYST
Series B Convertible Preferred Stock · derivative
|
2019-11-04 | Conversion | 609,965 | ||
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2019-11-04 | Buy | 501,375 | $16.00 | 8,022,000 |
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2019-11-04 | Conversion | 609,965 | ||
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2019-11-04 | Buy | 248,625 | $16.00 | 3,978,000 |